|
US5739166A
(en)
*
|
1994-11-29 |
1998-04-14 |
G.D. Searle & Co. |
Substituted terphenyl compounds for the treatment of inflammation
|
|
US5686470A
(en)
*
|
1995-02-10 |
1997-11-11 |
Weier; Richard M. |
2, 3-substituted pyridines for the treatment of inflammation
|
|
US5596008A
(en)
*
|
1995-02-10 |
1997-01-21 |
G. D. Searle & Co. |
3,4-Diaryl substituted pyridines for the treatment of inflammation
|
|
CA2412968C
(en)
*
|
1996-07-18 |
2010-05-11 |
Merck Frosst Canada & Co. |
Substituted pyridines as selective cyclooxygenase-2 inhibitors
|
|
US5861419A
(en)
*
|
1996-07-18 |
1999-01-19 |
Merck Frosst Canad, Inc. |
Substituted pyridines as selective cyclooxygenase-2 inhibitors
|
|
PT933346E
(pt)
|
1996-07-31 |
2004-03-31 |
Shionogi & Co |
Novos compostos de p-terfenilo
|
|
US6525053B1
(en)
|
1997-08-22 |
2003-02-25 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
|
US6307047B1
(en)
|
1997-08-22 |
2001-10-23 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
|
US6046217A
(en)
*
|
1997-09-12 |
2000-04-04 |
Merck Frosst Canada & Co. |
2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
|
|
US6004950A
(en)
*
|
1997-09-12 |
1999-12-21 |
Merck Frosst Canada, Inc. |
2-aminopyridines as inhibitors of cyclooxygenase-2
|
|
US6040450A
(en)
*
|
1997-09-25 |
2000-03-21 |
Merck & Co., Inc. |
Process for making diaryl pyridines useful as cox-2-inhibitors
|
|
AR015938A1
(es)
|
1997-09-25 |
2001-05-30 |
Merck Sharp & Dohme |
Procedimiento para preparar diaril piridinas utiles como inhibidores cox-2 y compuesto intermediario
|
|
US7041694B1
(en)
|
1997-12-17 |
2006-05-09 |
Cornell Research Foundation, Inc. |
Cyclooxygenase-2 inhibition
|
|
DK1685839T3
(da)
|
1997-12-22 |
2013-06-24 |
Euro Celtique Sa |
Farmaceutisk oral doseringsform omfattende en kombination af en opioidagonist og opioidantagonist
|
|
CN1204890C
(zh)
*
|
1997-12-22 |
2005-06-08 |
欧罗赛铁克股份有限公司 |
防止阿片样物质滥用的方法
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
US7253165B2
(en)
*
|
1999-09-14 |
2007-08-07 |
Aventis Pharmaceuticals Inc. |
Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
|
|
US7091199B1
(en)
|
1999-09-14 |
2006-08-15 |
Aventis Pharmaceuticals Inc. |
Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
|
|
US7125903B1
(en)
|
1999-09-14 |
2006-10-24 |
Aventis Pharmaceuticals Inc. |
Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
|
|
DE10001166A1
(de)
|
2000-01-13 |
2001-07-19 |
Merckle Gmbh |
Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung
|
|
AU776666B2
(en)
|
2000-02-08 |
2004-09-16 |
Euro-Celtique S.A. |
Tamper-resistant oral opioid agonist formulations
|
|
PL357158A1
(en)
|
2000-02-08 |
2004-07-12 |
Euro-Celtique, S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
|
PH12001001175B1
(en)
*
|
2000-05-26 |
2006-08-10 |
Merck Sharp & Dohme |
5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis
|
|
US6664256B1
(en)
|
2000-07-10 |
2003-12-16 |
Kowa Co., Ltd. |
Phenylpyridazine compounds and medicines containing the same
|
|
DE60122939T2
(de)
*
|
2000-12-21 |
2007-01-11 |
Nitromed, Inc., Bedford |
Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren
|
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
|
CN1525851A
(zh)
|
2001-05-11 |
2004-09-01 |
������ҩ������˾ |
抗滥用阿片样物质控释剂型
|
|
US7943173B2
(en)
*
|
2001-07-18 |
2011-05-17 |
Purdue Pharma L.P. |
Pharmaceutical combinations of oxycodone and naloxone
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
US20030044458A1
(en)
*
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
WO2003013525A1
(en)
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Opioid agonist formulations with releasable and sequestered antagonist
|
|
US20030157168A1
(en)
*
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
|
KR100809489B1
(ko)
*
|
2001-10-10 |
2008-03-03 |
씨제이제일제당 (주) |
사이클로옥시게나제-2의 저해제로서 선택성이 뛰어난4'-메탄설포닐-비페닐 유도체
|
|
GB0128996D0
(en)
|
2001-12-04 |
2002-01-23 |
Novartis Ag |
Organic compounds
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
US6797825B2
(en)
|
2001-12-13 |
2004-09-28 |
Abbott Laboratories |
Protein kinase inhibitors
|
|
CA2479744A1
(en)
*
|
2002-03-28 |
2003-10-09 |
Paul E. Finke |
Substituted 2,3-diphenyl pyridines
|
|
CA2478515C
(en)
|
2002-04-05 |
2010-09-28 |
Purdue Pharma |
Pharmaceutical preparation containing oxycodone and naloxone
|
|
AU2003261281A1
(en)
*
|
2002-07-29 |
2004-02-16 |
Nicox S.A. |
Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
|
|
DK1551372T3
(en)
|
2002-09-20 |
2018-07-23 |
Alpharma Pharmaceuticals Llc |
SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
|
|
EP1556083B1
(en)
*
|
2002-10-08 |
2011-02-02 |
Rinat Neuroscience Corp. |
Methods for treating post-surgical pain by admisnistering an antibody against nerve growth factor and compositions containing the same
|
|
US7255860B2
(en)
|
2002-10-08 |
2007-08-14 |
Rinat Neuroscience Corp. |
Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody
|
|
GB0225548D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Compounds
|
|
ATE468114T1
(de)
*
|
2002-11-08 |
2010-06-15 |
High Point Pharmaceuticals Llc |
Sichere chemische entkuppler zur behandlung von fettsucht
|
|
US20040102421A1
(en)
*
|
2002-11-21 |
2004-05-27 |
Children's Hospital Research Center At Oakland |
Tocopherol and tocotrienol anti-inflammatory medicaments
|
|
US7569364B2
(en)
*
|
2002-12-24 |
2009-08-04 |
Pfizer Inc. |
Anti-NGF antibodies and methods using same
|
|
EP2270048B1
(en)
*
|
2002-12-24 |
2015-11-11 |
Rinat Neuroscience Corp. |
Anti-NGF antibodies and methods using same
|
|
US9498530B2
(en)
|
2002-12-24 |
2016-11-22 |
Rinat Neuroscience Corp. |
Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
|
|
KR20050111598A
(ko)
|
2003-02-19 |
2005-11-25 |
리나트 뉴로사이언스 코퍼레이션 |
신경 성장 인자 길항제 및 ｎｓａｉｄ를 투여함으로써통증을 치료하는 방법 및 그것을 함유하는 조성물
|
|
WO2004080966A1
(ja)
|
2003-03-14 |
2004-09-23 |
Ono Pharmaceutical Co., Ltd. |
含窒素複素環誘導体およびそれらを有効成分とする薬剤
|
|
TWI347201B
(en)
*
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
EP1663229B1
(en)
|
2003-09-25 |
2010-04-14 |
Euro-Celtique S.A. |
Pharmaceutical combinations of hydrocodone and naltrexone
|
|
WO2005044227A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Glenmark Pharmaceuticals Limited |
Topical pharmaceutical compositions
|
|
US20050100594A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Nilendu Sen |
Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor
|
|
AU2005243247B2
(en)
|
2004-04-07 |
2012-03-01 |
Regents Of The University Of Minnesota |
Methods for treating bone cancer pain by administering a nerve growth factor antagonist
|
|
EP1604666A1
(en)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
|
EP1765292B1
(en)
|
2004-06-12 |
2017-10-04 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent drug formulations
|
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7271383B2
(en)
*
|
2004-08-11 |
2007-09-18 |
Lexmark International, Inc. |
Scanning system with feedback for a MEMS oscillating scanner
|
|
NZ553696A
(en)
|
2004-09-13 |
2010-02-26 |
Ono Pharmaceutical Co |
Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
|
|
GB0611907D0
(en)
|
2006-06-15 |
2006-07-26 |
Glaxo Group Ltd |
Compounds
|
|
EP1702558A1
(en)
*
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
|
MY150098A
(en)
*
|
2005-07-26 |
2013-11-29 |
Glaxo Group Ltd |
Benzylpiperazine derivates and their medical use
|
|
WO2007105637A1
(ja)
|
2006-03-10 |
2007-09-20 |
Ono Pharmaceutical Co., Ltd. |
含窒素複素環誘導体およびそれらを有効成分とする薬剤
|
|
KR101486228B1
(ko)
*
|
2006-06-19 |
2015-01-26 |
알파마 파머슈티컬스 엘엘씨 |
약제학적 조성물
|
|
PL2041093T3
(pl)
*
|
2006-06-28 |
2010-09-30 |
Glaxo Group Ltd |
Pochodne piperazynylowe użyteczne w leczeniu zaburzeń, którym pośredniczy receptor GPR38
|
|
CA2963784A1
(en)
|
2007-06-08 |
2008-12-18 |
Mannkind Corporation |
Ire-1.alpha. inhibitors
|
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
|
AU2008346870A1
(en)
*
|
2007-12-17 |
2009-07-16 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
|
US8623418B2
(en)
*
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
|
KR20130105935A
(ko)
*
|
2008-07-07 |
2013-09-26 |
유로-셀티큐 에스.에이. |
요폐의 치료를 위한 아편유사제 길항제의 용도
|
|
US20100160351A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
|
|
WO2010071865A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
|
|
EP2479166B1
(en)
|
2009-02-27 |
2014-08-20 |
Cadila Healthcare Limited |
A process for the preparation of etoricoxib
|
|
WO2010103039A1
(en)
|
2009-03-10 |
2010-09-16 |
Euro-Celtique S.A. |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
|
WO2011032175A1
(en)
|
2009-09-14 |
2011-03-17 |
Nuon Therapeutics, Inc. |
Combination formulations of tranilast and allopurinol and methods related thereto
|
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
CA2804593C
(en)
|
2010-07-09 |
2015-11-24 |
Pfizer Limited |
Biphenyloxybenzensulphonamide derivatives useful as sodium channel inhibitors
|
|
WO2012024650A2
(en)
|
2010-08-19 |
2012-02-23 |
Abbott Laboratories |
Anti-ngf antibodies and their use
|
|
EP2826467B1
(en)
|
2010-12-22 |
2017-08-02 |
Purdue Pharma L.P. |
Encased tamper resistant controlled release dosage forms
|
|
PH12013501345A1
(en)
|
2010-12-23 |
2022-10-24 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
|
JP5889029B2
(ja)
*
|
2011-02-14 |
2016-03-22 |
旭化成イーマテリアルズ株式会社 |
ハロゲン原子を有する多環式芳香族化合物の製造方法
|
|
SG10201604040PA
(en)
|
2011-05-20 |
2016-07-28 |
Alderbio Holdings Llc |
Anti-cgrp compositions and use thereof
|
|
WO2013105106A1
(en)
|
2011-11-03 |
2013-07-18 |
Cadila Healthcare Limited |
An improved process for the preparation of etoricoxib and polymorphs thereof
|
|
JP6629069B2
(ja)
|
2012-06-06 |
2020-01-15 |
ゾエティス・エルエルシー |
イヌ化抗ｎｇｆ抗体およびその方法
|
|
HUE033525T2
(en)
|
2012-08-27 |
2017-12-28 |
Cadila Healthcare Ltd |
Pharmaceuticals containing Etoricoxib
|
|
CN105120846B
(zh)
|
2013-02-05 |
2019-10-18 |
普渡制药公司 |
抗篡改的药物制剂
|
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
KR20180037074A
(ko)
|
2013-07-23 |
2018-04-10 |
유로-셀티큐 에스.에이. |
장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
|
|
CA3020839A1
(en)
|
2016-04-15 |
2017-10-19 |
Alder Biopharmaceuticals, Inc. |
Anti-pacap antibodies and uses thereof
|
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
|
SG11202002032SA
(en)
|
2017-09-22 |
2020-04-29 |
Jubilant Epipad LLC |
Heterocyclic compounds as pad inhibitors
|
|
CA3076476A1
(en)
|
2017-10-18 |
2019-04-25 |
Jubilant Epipad LLC |
Imidazo-pyridine compounds as pad inhibitors
|
|
BR112020008851A2
(pt)
|
2017-11-06 |
2020-10-20 |
Jubilant Prodel LLC |
composto da fórmula i, processo de preparação de compostos da fórmula i, composição farmacêutica, método para o tratamento e/ou prevenção de várias doenças, uso, método para o tratamento de câncer, método de tratamento de câncer e método para o tratamento e/ou prevenção de câncer e doenças infecciosas
|
|
PL3704120T3
(pl)
|
2017-11-24 |
2024-09-16 |
Jubilant Episcribe Llc |
Związki heterocykliczne jako inhibitory prmt5
|
|
MX2020009526A
(es)
|
2018-03-12 |
2020-10-28 |
Zoetis Services Llc |
Anticuerpos anti-ngf y metodos de estos.
|
|
SG11202008950PA
(en)
|
2018-03-13 |
2020-10-29 |
Jubilant Prodel LLC |
Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation
|
|
US20250215069A1
(en)
|
2021-08-27 |
2025-07-03 |
H. Lundbeck A/S |
Treatment of cluster headache using anti-cgrp antibodies
|
|
CN117776987A
(zh)
*
|
2022-09-27 |
2024-03-29 |
苏州阿尔脉生物科技有限公司 |
苯并[7]环烯类衍生物、包含其的药物组合物及其医药用途
|
|
US20260001942A1
(en)
|
2024-06-21 |
2026-01-01 |
H. Lundbeck A/S |
Treatment of headache disorders and/or psychiatric symptoms using anti-cgrp antibodies, and compositions and methods related thereto
|